A detailed history of Federated Hermes, Inc. transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 483 shares of TERN stock, worth $2,830. This represents 0.0% of its overall portfolio holdings.

Number of Shares
483
Previous 1,216 60.28%
Holding current value
$2,830
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$6.49 - $10.8 $4,757 - $7,916
-733 Reduced 60.28%
483 $4,000
Q2 2024

Aug 08, 2024

BUY
$4.54 - $8.2 $5,520 - $9,971
1,216 New
1,216 $8,000
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.29 $1,234 - $2,232
168 New
168 $1,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.